Dimensional Fund Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.58B Buy
3,895,925
+124,352
+3% +$126M 0.74% 12
2025
Q4
$4.05B Buy
3,771,573
+7,651
+0.2% +$7.32M 0.85% 9
2025
Q3
$2.87B Buy
3,763,922
+73,658
+2% +$54.8M 0.62% 14
2025
Q2
$2.88B Sell
3,690,264
-106,021
-3% -$82.4M 0.67% 13
2025
Q1
$3.14B Buy
3,796,285
+94,078
+3% +$78.3M 0.78% 9
2024
Q4
$2.86B Buy
3,702,207
+47,373
+1% +$39.2M 0.69% 10
2024
Q3
$3.24B Buy
3,654,834
+73,759
+2% +$66.3M 0.79% 9
2024
Q2
$3.24B Buy
3,581,075
+171,595
+5% +$137M 0.85% 8
2024
Q1
$2.65B Buy
3,409,480
+13,584
+0.4% +$9.67M 0.72% 9
2023
Q4
$1.98B Buy
3,395,896
+28,104
+0.8% +$16.4M 0.58% 12
2023
Q3
$1.81B Buy
3,367,792
+51,826
+2% +$26.7M 0.59% 12
2023
Q2
$1.56B Buy
3,315,966
+100,101
+3% +$42M 0.5% 16
2023
Q1
$1.1B Buy
3,215,865
+29,401
+0.9% +$9.92M 0.37% 28
2022
Q4
$1.17M Buy
3,186,464
+54,887
+2% +$19.5M 0.34% 34
2022
Q3
$1.01B Buy
3,131,577
+61,303
+2% +$19.4M 0.39% 24
2022
Q2
$995M Buy
3,070,274
+72,889
+2% +$21.9M 0.36% 31
2022
Q1
$858M Sell
2,997,385
-10,431
-0.3% -$2.68M 0.26% 49
2021
Q4
$831M Buy
3,007,816
+9,290
+0.3% +$2.36M 0.25% 49
2021
Q3
$693M Sell
2,998,526
-17,931
-0.6% -$4.43M 0.22% 56
2021
Q2
$692M Buy
3,016,457
+28,284
+0.9% +$5.68M 0.22% 57
2021
Q1
$558M Buy
2,988,173
+24,622
+0.8% +$4.82M 0.18% 72
2020
Q4
$500M Buy
2,963,551
+50,192
+2% +$7.49M 0.18% 77
2020
Q3
$431M Buy
2,913,359
+51,176
+2% +$7.92M 0.18% 76
2020
Q2
$470M Buy
2,862,183
+67,808
+2% +$10.4M 0.21% 62
2020
Q1
$388M Buy
2,794,375
+369,568
+15% +$50.8M 0.2% 62
2019
Q4
$319M Buy
2,424,807
+32,808
+1% +$3.8M 0.12% 116
2019
Q3
$268M Buy
2,391,999
+55,165
+2% +$6.14M 0.1% 135
2019
Q2
$259M Buy
2,336,834
+422,038
+22% +$49.7M 0.1% 140
2019
Q1
$248M Sell
1,914,796
-155,791
-8% -$18.9M 0.1% 140
2018
Q4
$240M Buy
2,070,587
+18,958
+0.9% +$2.12M 0.11% 128
2018
Q3
$220M Buy
2,051,629
+36,980
+2% +$3.7M 0.08% 203
2018
Q2
$172M Buy
2,014,649
+108,534
+6% +$8.91M 0.07% 288
2018
Q1
$147M Buy
1,906,115
+36,428
+2% +$2.93M 0.06% 362
2017
Q4
$158M Sell
1,869,687
-61,603
-3% -$5.24M 0.07% 323
2017
Q3
$165M Sell
1,931,290
-9,917
-0.5% -$813K 0.07% 287
2017
Q2
$160M Buy
1,941,207
+114,913
+6% +$9.38M 0.07% 269
2017
Q1
$154M Buy
1,826,294
+135,153
+8% +$10.8M 0.07% 280
2016
Q4
$124M Buy
1,691,141
+49,734
+3% +$3.7M 0.06% 369
2016
Q3
$132M Buy
1,641,407
+55,028
+3% +$4.4M 0.07% 296
2016
Q2
$125M Sell
1,586,379
-670
-0% -$50.4K 0.07% 287
2016
Q1
$114M Buy
1,587,049
+98,778
+7% +$7.47M 0.07% 305
2015
Q4
$125M Buy
1,488,271
+105,381
+8% +$8.75M 0.08% 256
2015
Q3
$116M Buy
1,382,890
+36,269
+3% +$3.06M 0.08% 271
2015
Q2
$112M Buy
1,346,621
+129,096
+11% +$9.84M 0.07% 316
2015
Q1
$88.5M Sell
1,217,525
-8,641
-0.7% -$615K 0.06% 412
2014
Q4
$84.6M Buy
1,226,166
+48,918
+4% +$3.3M 0.06% 394
2014
Q3
$76.4M Buy
1,177,248
+19,247
+2% +$1.22M 0.05% 407
2014
Q2
$72M Buy
1,158,001
+30,491
+3% +$1.82M 0.05% 464
2014
Q1
$66.4M Buy
1,127,510
+127,796
+13% +$7.13M 0.05% 462
2013
Q4
$51M Sell
999,714
-6,027
-0.6% -$302K 0.04% 597
2013
Q3
$50.6M Buy
1,005,741
+7,881
+0.8% +$413K 0.04% 525
2013
Q2
$49M Buy
+997,860
New +$54.3M 0.05% 502

Other funds holding LLY

Dimensional Fund Advisors's LLY Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Eli Lilly (LLY) stake by 3.3% in Q1 2026, buying an estimated $126M and bringing the position to 3,895,925 shares worth $3.58B. The position accounts for 0.74% of the portfolio, ranked #12.

Dimensional Fund Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.05B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Dimensional Fund Advisors held 3,895,925 shares of Eli Lilly worth $3.58B as of Q1 2026.
  • Dimensional Fund Advisors bought 124,352 Eli Lilly shares in Q1 2026, an estimated $126M.
  • Eli Lilly made up 0.74% of Dimensional Fund Advisors's portfolio in Q1 2026, its #12 holding.
  • Dimensional Fund Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Dimensional Fund Advisors's Eli Lilly position peaked at $4.05B in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.